We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

461 hedge funds and large institutions have $9.45B invested in United Therapeutics in 2022 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 170 increasing their positions, 160 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more call options, than puts

Call options by funds: $104M | Put options by funds: $51M

2.74% more ownership

Funds ownership: 97.2% → 99.94% (+2.7%)

6% more repeat investments, than reductions

Existing positions increased: 170 | Existing positions reduced: 160

2% less funds holding

Funds holding: 472 → 461 (-11)

9% less capital invested

Capital invested by funds: $10.3B → $9.45B (-$878M)

11% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 61

25% less funds holding in top 10

Funds holding in top 10: 24 → 18 (-6)

Holders
461
Holders Change
-11
Holders Change %
-2.33%
% of All Funds
7.94%
Holding in Top 10
18
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-25%
% of All Funds
0.31%
New
54
Increased
170
Reduced
160
Closed
61
Calls
$104M
Puts
$51M
Net Calls
+$53.1M
Net Calls Change
+$3.64M

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$211M
2
Citadel Advisors
Citadel Advisors
Florida
+$124M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$63.7M
4
APM
Avidity Partners Management
Texas
+$54.7M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$36.6M

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$54.4M
2
PAMS
Pictet Asset Management (Switzerland)
Switzerland
-$41.7M
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$39M
4
American Century Companies
American Century Companies
Missouri
-$36.1M
5
First Trust Advisors
First Trust Advisors
Illinois
-$35.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
CIBC World Market
501
CIBC World Market
Ontario, Canada
– -$234K -991 Closed
HighTower Advisors
502
HighTower Advisors
Illinois
– -$221K -940 Closed
SF
503
Synovus Financial
Georgia
– -$212K -900 Closed
BAMF
504
BI Asset Management Fondsmaeglerselskab
Denmark
– -$208K -884 Closed
GT
505
Greenleaf Trust
Michigan
– -$204K -867 Closed
V
506
Veritable
Delaware
– -$202K -858 Closed
ZB
507
Zions Bancorporation
Utah
– -$78K -331 Closed
GCM
508
Gladius Capital Management
Illinois
– -$71K -301 Closed
CMBA
509
C.M. Bidwell & Associates
Hawaii
– -$59K -250 Closed
NICM
510
Neo Ivy Capital Management
New York
– -$48K -205 Closed
COCM
511
Charter Oak Capital Management
New Hampshire
– -$25K -105 Closed
GLLW
512
Graves Light Lenhart Wealth
Virginia
– -$24K -100 Closed
SFG
513
Steward Financial Group
Texas
– -$11K -50 Closed
CCM
514
Chilton Capital Management
Texas
– -$12K -49 Closed
TCWM
515
Total Clarity Wealth Management
Illinois
– -$11K -47 Closed
GIA
516
GHP Investment Advisors
Colorado
– -$7K -31 Closed
PFGIA
517
Patriot Financial Group Insurance Agency
Massachusetts
– -$7K -28 Closed
STCOSD
518
Sageworth Trust Company of South Dakota
South Dakota
– -$6K -26 Closed
CWP
519
Concord Wealth Partners
Virginia
– -$4K -15 Closed
FHA
520
First Horizon Advisors
Tennessee
– -$1.34K -6 -60%
MBFW
521
Morton Brown Family Wealth
Pennsylvania
– -$1K -3 Closed
CAL
522
Capital Advisors Ltd
Ohio
– +$447 +2 New
17 18 19 20
21

UTHR Hedge Fund Activity: Q3 2022 in Review

461 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q3 2022, worth a combined $9.45B — down 8.5% from $10.3B a quarter earlier.

Sellers outnumbered buyers: 61 funds closed out of UTHR and 54 opened new positions — a net loss of 7 holders — while 160 trimmed existing stakes and 170 added.

The largest buyer was Janus Henderson Group, adding an estimated $211M. The largest seller was Renaissance Technologies, cutting an estimated $54.4M.

  • 461 institutional investors held United Therapeutics (UTHR) as of Q3 2022, down from 472 in Q2 2022.
  • Funds reported $9.45B of United Therapeutics stock for Q3 2022, down 8.5% quarter-over-quarter.
  • 54 funds opened new United Therapeutics positions in Q3 2022 and 61 closed out, a net change of -7 holders.
  • The largest United Therapeutics buyer in Q3 2022 was Janus Henderson Group, an estimated $211M added.
  • The largest United Therapeutics seller in Q3 2022 was Renaissance Technologies, an estimated $54.4M sold.

Based on aggregated 13F filings for Q3 2022.